Uncategorized Bernstein Reaffirms Buy Rating on DraftKings, Citing Live Betting and Jackpocket Synergies Post Content
Uncategorized Cantor Fitzgerald Maintains Price Target on MongoDB, Sees Atlas Usage Rebound Post Content
Uncategorized SharkNinja Maintains 9.5% Sales Target Despite Tariffs and Inventory Disruptions Post Content
Uncategorized Oppenheimer Reaffirms Outperform on Revolution Medicines, Cites PDAC and NSCLC Trial Progress Post Content
Uncategorized GitLab Maintains Buy Rating Despite Lowered Price Target, Shows Strong Seat Expansion Post Content